annual CFI:
-$189.87M-$458.60M(-170.65%)Summary
- As of today (June 3, 2025), SUPN annual cash flow from investing activities is -$189.87 million, with the most recent change of -$458.60 million (-170.65%) on December 31, 2024.
- During the last 3 years, SUPN annual CFI has fallen by -$107.95 million (-131.79%).
- SUPN annual CFI is now -170.65% below its all-time high of $268.73 million, reached on December 31, 2023.
Performance
SUPN Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$37.32M+$49.95M(+395.28%)Summary
- As of today (June 3, 2025), SUPN quarterly cash flow from investing activities is $37.32 million, with the most recent change of +$49.95 million (+395.28%) on March 31, 2025.
- Over the past year, SUPN quarterly CFI has increased by +$88.94 million (+172.29%).
- SUPN quarterly CFI is now -84.44% below its all-time high of $239.78 million, reached on March 31, 2023.
Performance
SUPN quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$100.93M+$88.94M(+46.84%)Summary
- As of today (June 3, 2025), SUPN TTM cash flow from investing activities is -$100.93 million, with the most recent change of +$88.94 million (+46.84%) on March 31, 2025.
- Over the past year, SUPN TTM CFI has dropped by -$78.25 million (-345.10%).
- SUPN TTM CFI is now -135.30% below its all-time high of $285.94 million, reached on September 30, 2023.
Performance
SUPN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
SUPN Cash from investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -170.7% | +172.3% | -345.1% |
3 y3 years | -131.8% | +153.3% | -25.4% |
5 y5 years | -20.2% | +5.3% | -424.6% |
SUPN Cash from investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -170.7% | +12.4% | -84.4% | +145.4% | -135.3% | +58.5% |
5 y | 5-year | -170.7% | +12.4% | -84.4% | +134.5% | -135.3% | +58.5% |
alltime | all time | -170.7% | +54.1% | -84.4% | +108.8% | -135.3% | +80.3% |
SUPN Cash from investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $37.32M(-395.3%) | -$100.93M(-46.8%) |
Dec 2024 | -$189.87M(-170.7%) | -$12.64M(-83.6%) | -$189.87M(-21.9%) |
Sep 2024 | - | -$77.01M(+58.5%) | -$243.21M(+84.9%) |
Jun 2024 | - | -$48.59M(-5.9%) | -$131.56M(+480.2%) |
Mar 2024 | - | -$51.62M(-21.8%) | -$22.68M(-108.4%) |
Dec 2023 | $268.73M(-224.0%) | -$65.98M(-290.5%) | $268.73M(-6.0%) |
Sep 2023 | - | $34.63M(-42.6%) | $285.94M(+69.1%) |
Jun 2023 | - | $60.30M(-74.9%) | $169.08M(+81.6%) |
Mar 2023 | - | $239.78M(-591.7%) | $93.10M(-143.0%) |
Dec 2022 | -$216.66M(+164.5%) | -$48.77M(-40.7%) | -$216.66M(+136.1%) |
Sep 2022 | - | -$82.23M(+424.5%) | -$91.77M(+502.2%) |
Jun 2022 | - | -$15.68M(-77.6%) | -$15.24M(-81.1%) |
Mar 2022 | - | -$69.99M(-191.9%) | -$80.45M(-1.8%) |
Dec 2021 | -$81.91M(+136.1%) | $76.13M(-1434.7%) | -$81.91M(-24.6%) |
Sep 2021 | - | -$5.70M(-92.9%) | -$108.70M(-4.9%) |
Jun 2021 | - | -$80.89M(+13.2%) | -$114.30M(-19.3%) |
Mar 2021 | - | -$71.44M(-244.8%) | -$141.58M(+308.0%) |
Dec 2020 | -$34.70M(-78.0%) | $49.34M(-536.6%) | -$34.70M(-46.3%) |
Sep 2020 | - | -$11.30M(-89.6%) | -$64.61M(+4.8%) |
Jun 2020 | - | -$108.18M(-405.3%) | -$61.66M(+220.5%) |
Mar 2020 | - | $35.44M(+82.3%) | -$19.24M(-87.8%) |
Dec 2019 | -$157.92M(-61.8%) | $19.44M(-332.7%) | -$157.92M(+10.4%) |
Sep 2019 | - | -$8.36M(-87.3%) | -$143.03M(+30.8%) |
Jun 2019 | - | -$65.76M(-36.3%) | -$109.34M(-76.5%) |
Mar 2019 | - | -$103.25M(-400.7%) | -$465.72M(+12.6%) |
Dec 2018 | -$413.48M(+378.5%) | $34.33M(+35.5%) | -$413.48M(-11.4%) |
Sep 2018 | - | $25.34M(-106.0%) | -$466.94M(-9.1%) |
Jun 2018 | - | -$422.14M(+727.6%) | -$513.44M(+340.1%) |
Mar 2018 | - | -$51.01M(+166.7%) | -$116.66M(+35.0%) |
Dec 2017 | -$86.42M | -$19.13M(-9.6%) | -$86.42M(+6.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2017 | - | -$21.16M(-16.6%) | -$80.93M(+15.4%) |
Jun 2017 | - | -$25.36M(+22.2%) | -$70.12M(+52.2%) |
Mar 2017 | - | -$20.76M(+52.2%) | -$46.08M(+28.1%) |
Dec 2016 | -$35.96M(-8.5%) | -$13.64M(+31.8%) | -$35.96M(+2.2%) |
Sep 2016 | - | -$10.35M(+682.9%) | -$35.19M(+4.7%) |
Jun 2016 | - | -$1.32M(-87.6%) | -$33.60M(-13.4%) |
Mar 2016 | - | -$10.65M(-17.2%) | -$38.82M(-1.2%) |
Dec 2015 | -$39.29M(+1377.6%) | -$12.87M(+46.9%) | -$39.29M(+14.3%) |
Sep 2015 | - | -$8.76M(+33.9%) | -$34.37M(+37.0%) |
Jun 2015 | - | -$6.54M(-41.2%) | -$25.09M(+106.5%) |
Mar 2015 | - | -$11.12M(+39.8%) | -$12.15M(+356.9%) |
Dec 2014 | -$2.66M(-78.0%) | -$7.95M(-1617.7%) | -$2.66M(-110.1%) |
Sep 2014 | - | $524.00K(-91.8%) | $26.20M(-13.5%) |
Jun 2014 | - | $6.40M(-492.8%) | $30.29M(-385.9%) |
Mar 2014 | - | -$1.63M(-107.8%) | -$10.59M(-12.5%) |
Dec 2013 | -$12.11M(-75.3%) | $20.91M(+354.0%) | -$12.11M(-71.4%) |
Sep 2013 | - | $4.61M(-113.4%) | -$42.37M(-26.0%) |
Jun 2013 | - | -$34.48M(+994.9%) | -$57.28M(+87.5%) |
Mar 2013 | - | -$3.15M(-66.3%) | -$30.55M(-37.6%) |
Dec 2012 | -$48.96M(-244.4%) | -$9.35M(-9.3%) | -$48.96M(+245.2%) |
Sep 2012 | - | -$10.30M(+32.8%) | -$14.18M(-319.4%) |
Jun 2012 | - | -$7.76M(-64.0%) | $6.46M(-64.2%) |
Mar 2012 | - | -$21.55M(-184.8%) | $18.05M(-46.8%) |
Dec 2011 | $33.90M(+31.3%) | $25.43M(+145.9%) | $33.90M(+300.2%) |
Sep 2011 | - | $10.34M(+170.0%) | $8.47M(-552.8%) |
Jun 2011 | - | $3.83M(-167.2%) | -$1.87M(-67.2%) |
Mar 2011 | - | -$5.70M | -$5.70M |
Dec 2010 | $25.82M(-191.0%) | - | - |
Dec 2009 | -$28.39M(-283.4%) | - | - |
Dec 2008 | $15.48M(+4.2%) | - | - |
Dec 2007 | $14.85M | - | - |
FAQ
- What is Supernus Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual CFI year-on-year change?
- What is Supernus Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly CFI year-on-year change?
- What is Supernus Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals TTM CFI year-on-year change?
What is Supernus Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of SUPN is -$189.87M
What is the all time high annual CFI for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual cash flow from investing activities is $268.73M
What is Supernus Pharmaceuticals annual CFI year-on-year change?
Over the past year, SUPN annual cash flow from investing activities has changed by -$458.60M (-170.65%)
What is Supernus Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of SUPN is $37.32M
What is the all time high quarterly CFI for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly cash flow from investing activities is $239.78M
What is Supernus Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, SUPN quarterly cash flow from investing activities has changed by +$88.94M (+172.29%)
What is Supernus Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of SUPN is -$100.93M
What is the all time high TTM CFI for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high TTM cash flow from investing activities is $285.94M
What is Supernus Pharmaceuticals TTM CFI year-on-year change?
Over the past year, SUPN TTM cash flow from investing activities has changed by -$78.25M (-345.10%)